Cargando…
Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies
OBJECTIVE: Two cohort studies in patients with multisystem inflammatory syndrome in children (MIS‐C) demonstrated contrasting results regarding the benefit of initial immunomodulatory treatment with intravenous immunoglobulin (IVIG) alone versus IVIG and glucocorticoids. We sought to determine wheth...
Autores principales: | Melgar, Michael, Seaby, Eleanor G., McArdle, Andrew J., Young, Cameron C., Campbell, Angela P., Murray, Nancy L., Patel, Manish M., Levin, Michael, Randolph, Adrienne G., Son, Mary Beth F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469482/ https://www.ncbi.nlm.nih.gov/pubmed/35759535 http://dx.doi.org/10.1002/acr2.11478 |
Ejemplares similares
-
The immunopathogenesis of SARS‐CoV‐2 infection in children: diagnostics, treatment and prevention
por: Patel, Harsita, et al.
Publicado: (2022) -
Treatment of Multisystem Inflammatory Syndrome in Children
por: McArdle, Andrew J., et al.
Publicado: (2021) -
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
por: Channon-Wells, Samuel, et al.
Publicado: (2023) -
Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1
por: Lee, Pui Y., et al.
Publicado: (2020) -
Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
por: Blatz, Allison M., et al.
Publicado: (2022)